Atlas Trials

Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C

Clinical trial NCT00491244 · COMPLETED

Trial details

NCT number
NCT00491244
Sponsor
National Taiwan University Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis C
Start date
2007-06-01
Primary completion
2013-09-01
Enrollment
377

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.